Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Blog

Home Search results for "CRO"

List of 28 in Vitro Diagnostic Reagent Registration and Clinical Trial CRO Service Providers

By medicilon | Featured Stories | Comments are Closed | 11 January, 2021 |

Similar to medical CRO companies, medical device CRO services are essentially a form of service outsourcing. Attached to the medical device industry, the upstream is medical institutions that provide clinical data for medical devices, and the downstream is medical device companies. The main source of business in the industry is the entrustment of medical deviceRead more

Medicilon is Listed as the 2020 TOP10 Innovation CRO in China

By medicilon | Medicilon Events | Comments are Closed | 25 December, 2020 |

Dec.20, 2020, Hebei—The 13th China Pharmaceutical Strategy Conference 2020 was held successfully. The conference presented the list of “the 2020 TOP10 Innovation CRO in China”. The list included the 10 CRO that made tremendous innovation and achievements and Medicilon was honored to be one of the 10. 13th China Pharmaceutical Strategy Conference In the pastRead more

The Scale of the Drug Discovery CRO Industry Continues to Grow

By medicilon | Featured Stories | Comments are Closed | 24 December, 2020 |

The development of new drugs is booming, and drug discovery determines the success or failure of drug development. The research and development of new drugs is the source of innovation in the global pharmaceutical industry and is of great significance to human health and life safety. In 2019, the Center for Drug Evaluation and ResearchRead more

Small CRO-Opportunities and Challenges of Clinical Research

By medicilon | Featured Stories | Comments are Closed | 23 December, 2020 |

2017 is so extraordinary For the research and development industry of drugs and medical devices, 2017 is destined to be an extraordinary year. For clinical researchers, this “extraordinary” year is mainly reflected in the following five aspects: More in-depth self-examination After the self-inspection verification announcement was issued on July 22, 2015, regardless of the sponsor,Read more

CRO or Not? The Advantages and Disadvantages of Three Choices in Clinical Research

By medicilon | Featured Stories | Comments are Closed | 23 December, 2020 |

There is no standard answer to the question whether the sponsor establishes a team of monitors to do clinical research or outsources clinical research to CRO. Sponsors often outsource a large number of projects to CROs. After a period of time, they find that there is a problem with the quality of control, and thenRead more

The Latest TOP10 Ranking of Global CRO Companies

By medicilon | Featured Stories | Comments are Closed | 22 December, 2020 |

Former Fierce Markets writer and current independent writer Arsalan Arif recently published the latest ranking of global CRO companies. Let me share with you here that the ranking is based on market value. The data source is mainly based on the financial reports of listed companies, while the unlisted companies are estimated by reliable informationRead more

New Drug Development CRO

By medicilon | Featured Stories | Comments are Closed | 12 June, 2020 |

New drug development is a systematic project, and the corresponding CRO service also covers the entire process of drug development from the discovery stage, pre-clinical research, clinical research to new drug registration and declaration. The basic process of new drug development Formulate research plan, design and implement experimental plan, and obtain NCEPre-clinical research, obtain INDRead more

Medicilon was awarded “2019 Excellent Listed Enterprise” at ZJ Science City Annual Event

By medicilon | Featured Stories | Comments are Closed | 13 January, 2020 |

Medicilon was awarded “2019 Excellent Listed Enterprise” for its remarkable innovation and advances in the year 2019, at ZJ Science City Annual Event in Jan. 10th, 2020. This award showcased the huge progress Medicilon has made since going public in 2019 and would inspire Medicilon to keep the momentum in 2020 and achieve bigger success.Read more

The Development of the Pharmaceutical CRO Market

By medicilon | Featured Stories | Comments are Closed | 21 September, 2019 |

On a global scale, the pharmaceutical industry is facing tremendous pressure to control costs, because all large pharmaceutical companies are currently reducing their internal capabilities in manufacturing, R&D, and marketing, and costs are mainly turned to outsourcing. CRO has become an indispensable part of every pharmaceutical company because they often rely heavily on outsourcing servicesRead more

Memorabilia of the global biopharmaceutical CRO/CDMO industry in 2017

By medicilon | Featured Stories | Comments are Closed | 21 December, 2017 |

Unknowingly, biological drugs have occupied a leading position in the TOP10 list of global best-selling drugs, and Xiu Mei Le has been awarded the title of “Pharmaceutical King” for many years. There is no doubt that the popularity of biological medicine has overshadowed chemical medicine in recent years. With the breakthrough success of tumor immunotherapyRead more

12

About Us

  • Medicilon Overview
  • Executive Team
  • Company History
  • CEO Message
  • Honor
  • Customer Reviews
  • New Models of Collaboration
  • Intellectual Property Protection
  • Corporate Culture
  • Careers
  • Download Center
  • Contact

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc